Systematic review / meta-analysis / 2019
Heme iron intake and serum iron are linked to higher breast cancer risk.
A meta-analysis of 23 studies evaluated iron exposure and breast malignancy risk. Comparing extreme categories, heme iron consumption was linked to higher risk (pooled RR 1.12, 95% CI: 1.04-1.22), as were elevated circulating iron levels (RR 1.22, 95% CI: 1.01-1.47). In contrast, food-derived, supplement-based, or combined total intakes exhibited no significant relationships with breast cancer risk.
- Study type
- Systematic review and meta-analysis
- Who was studied
- 27 studies (23 eligible for meta-analysis)
- What was measured
- Breast cancer risk
THE PAPER
Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis.
Chang VC, Cotterchio M, Khoo E. BMC Cancer, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.